Although NAFLD primarily affects patients with metabolic syndrome, obesity, and diabetes, recognizing classical risk factors such as obesity, renin–angiotensin system activation (RAS), fructose metabolism dysregulation, and lipogenesis in the development of both disorders, evidence considers inflammatory disorder the principal mechanism involved [34]. The gene discussed is REN; the disease is Obesity.